Los Altos California based Efemoral Medical is raising $7,569,360.00 in New Equity Investment.
Los Altos, CA – According to filings with the U.S. Securities and Exchange Commission, Efemoral Medical is raising $7,569,360.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Christoper Haig played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Efemoral Medical
Efemoral Medical, Inc. is developing next-generation bioresorbable solutions to treat patients with vascular disease. The company’s initial product, the Efemoral Vascular Scaffold System (EVSS) with FlexStep Technology, is designed to offer a dedicated strategy for PAD interventions. The Efemoral Vascular Scaffold System (EVSS) is an OUS Investigational Device only. To learn more, please visit efemoralmedical.com.
To learn more about Efemoral Medical, visit http://efemoralmedical.com/
Contact:
Christoper Haig, Chief Executive Officer
408-718-1472
https://www.linkedin.com/in/christopher-haig-7b899512/
SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved